Shivalik Rasayan Limited Announces Quarterly Results for Q2 FY2026; AGM Set for September 28
Shivalik Rasayan Limited announced that its Board of Directors approved the Unaudited Financial Results for both Standalone and Consolidated operations for the quarter ended on June 30, 2026. The results were released in conjunction with several key corporate approvals, including the draft Annual Report for the financial year 2025-26.The company also announced that its 48th Annual General Meeting (AGM) is scheduled to be held on Monday, September 28, 2026, at 1:00 pm at Hotel Saffron Leaf in Dehradun, Uttarakhand.
Shareholder Meetings and Dividend Details
In related decisions taken by the Board of Directors, the company set specific dates concerning dividend payment and shareholder voting.The cut-off date for determining eligible shareholders for casting their vote was fixed as September 21, 2026. The period for electronic voting is scheduled from Friday, September 25, 2026, to Sunday, September 27, 2026.
Furthermore, the company decided to close its Register of Members and other Transfer books in preparation for the payment of a Final Dividend for the financial year 2025-26. The dividend is set at 10% or Rs. 0.50 per Equity Share, pending resolution by the members at the forthcoming AGM. The register closure period will run from Tuesday, September 22, 2026, to Monday, September 28, 2026.
Quarterly Financial Performance Highlights
The Unaudited Financial Results for Q2 ended June 30, 2026, showed strong performance across the company’s segments: Agrochemicals, Active Pharmaceutical Ingredients (API), and Pharmaceuticals Formulations.Total Consolidated Revenue for the quarter stood at 9,633.85 Rs. Lakhs, while Net Profit for the period was reported at 450.13 Rs. Lakhs. The Earnings Per Share (Basic) for the consolidated results was 2.16 Rs.
A detailed breakdown of the company’s performance across segments is provided below:
| Segment | Qended June 30, 2026 Revenue | Qended June 30, 2025 Revenue | Profit Before Tax (Qtr Ended 30-06-2026) |
|---|---|---|---|
| Agrochemicals | 4,382.58 Rs. Lakhs | 4,433.88 Rs. Lakhs | 631.34 Rs. Lakhs |
| Active Pharmaceutical Ingredient (API) | 217.91 Rs. Lakhs | 192.52 Rs. Lakhs | (197.56) Rs. Lakhs |
| Pharmaceuticals Formulations | 4,789.69 Rs. Lakhs | 4,304.48 Rs. Lakhs | 340.05 Rs. Lakhs |
| Total | 9,633.86 Rs. Lakhs | 17,023.35 Rs. Lakhs | 565.87 Rs. Lakhs |
Audit Review Confirmed
The Unaudited Financial Results were subjected to a Limited Review Report by M/s Rahul Chaudhary & Associates, Chartered Accountants. This review confirmed that the company’s management prepared the statements in accordance with Indian Accounting Standard 34 (Interim Financial Reporting). The limited review was conducted based on SRE 2410 and did not result in an audit opinion.A separate Limited Review Report for the consolidated unaudited financial results of the Group, which includes results from the associate Medicamen Biotech Limited, was also issued by Rahul Chaudhary & Associates.
SHIVALIK Stock Price Movement
Today, shares of Shivalik Rasayan Limited edged higher to close at ₹267.99, gaining 3.37% in a positive session. The stock traded within a range spanning from ₹255.00 to ₹269.00, with 35,168 shares transacted today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.